|
|
.
See Category: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
ICD-10 (CM) Code and Descriptor
|
D59.19 |
Other autoimmune hemolytic anemia
|
D5919 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 37.35%
|
23.52%
|
14.93%
|
8.64%
|
4.92%
|
3.25%
|
1.67%
|
2.27%
|
0.90%
|
0.70%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D59.19*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
1,528
|
1,529
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
1,351
|
1,357
|
|
80053
|
COMPREHEN METABOLIC PANEL |
1,019
|
1,019
|
|
83615
|
LACTATE (LD) (LDH) ENZYME |
894
|
894
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
581
|
581
|
|
83010
|
ASSAY OF HAPTOGLOBIN QUANT |
523
|
524
|
|
85045
|
AUTOMATED RETICULOCYTE COUNT |
494
|
494
|
|
85027
|
COMPLETE CBC AUTOMATED |
248
|
248
|
|
96413
|
CHEMO IV INFUSION 1 HR |
220
|
220
|
|
86880
|
COOMBS TEST DIRECT |
209
|
399
|
|
96415
|
CHEMO IV INFUSION ADDL HR |
194
|
368
|
|
96375
|
TX/PRO/DX INJ NEW DRUG ADDON |
193
|
276
|
|
82728
|
ASSAY OF FERRITIN |
187
|
187
|
|
85046
|
RETICYTE/HGB CONCENTRATE |
164
|
164
|
|
86900
|
BLOOD TYPING SEROLOGIC ABO |
164
|
166
|
|
J9312
|
INJ., RITUXIMAB, 10 MG |
164
|
6,315
|
|
83540
|
ASSAY OF IRON |
162
|
162
|
|
86901
|
BLOOD TYPING SEROLOGIC RH(D) |
161
|
164
|
|
86850
|
RBC ANTIBODY SCREEN |
153
|
160
|
|
96365
|
THER/PROPH/DIAG IV INF INIT |
146
|
146
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D59.19 related to the following DRG Codes:
808-810
|
